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Addison's disease (typical and atypical types) 
Prof. Dr. Claudia Reusch, Dipl ECVIM-CA 
Clinic for Small Animal Internal Medicine, University of Zurich, Switzerland 
 
Most dogs with naturally occurring hypoadrenocorticism suffer from primary hypoadrenocorticism 
which is also known as Addison’s disease (AD). It is currently assumed that the main cause is 
autoimmune destruction of the adrenal cortex. At least 90% of adrenocortical tissue has to be 
destroyed before clinical signs become apparent. In immune mediated AD tissue loss usually takes 
place in a slow and progressive manner over weeks to months. Typically, the destruction involves 
all three zones of the adrenal cortex and results in deficiency of both cortisol and aldosterone. 
Cortisol is required in almost all tissues of the body and its deficiency is associated with stress 
intolerance, weakness, gastrointestinal signs, hypotension, absence of a stress leucogram, anemia 
and hypoglycemia. Aldosterone acts mainly on the renal tubule to increase the absorption of Na+ 
and Cl- and the secretion of K+ and H+. Aldosterone deficiency therefore is typically characterized 
by variable degrees of hyperkalemia, metabolic acidosis and hyponatremia; sodium wasting in turn 
is associated with volume depletion. In primary hypoadrenocorticism, endogenous ACTH is highly 
elevated due to the negative feedback. Secondary hypoadrenocorticism is due to ACTH deficiency 
and has so far only rarely been described in dogs. It may result from destructive lesions in the 
pituitary or hypothalamus, such as neoplasia, inflammation, trauma or lymphocytic hypophysitis. 
Aldosterone secretion should not be impaired, as it is mainly regulated by the RAA system and the 
plasma potassium concentration. Differentiation between primary and secondary hypoaldosteronism 
is critical as the latter requires further workup (e.g. brain imaging) and prognosis may be guarded. 
In primary hypoadrenocorticism (AD), the typical or classical electrolyte abnormalities are 
hyperkalemia and/or hyponatremia, which occur in 80 – 90% of cases. Severity of the electrolyte 
alterations ranges from subtle to very severe and life-threatening. It should be remembered that 
although hyponatremia and hyperkalemia are often seen in dogs with AD, they are not specific for 
the disease. They may for instance be found in dogs with primary gastrointestinal diseases (most 
frequently associated with diarrhoea from trichuris infection), cortisol and aldosterone 
concentrations are not affected in those cases.  
In about 10% of dogs with AD, both sodium and potassium concentrations are within the normal 
range, which has been referred to as atypical AD. In those dogs, diagnosis may be delayed because 
the typical electrolyte changes are lacking and therefore the index of suspicion is low. When dogs 
with typical and atypical AD were compared, the latter were older at the time of diagnosis and had a 
longer duration of clinical signs which highlights the fact that the disease may go undetected for 
longer periods. It has been postulated that in dogs with atypical AD the destructive (e.g. immune-
mediated) process is confined to the zona fasciculata and zona reticularis, leading to an isolated 
glucocorticoid deficiency with intact aldosterone secretion. However, so far only very few data are 
available to confirm this assumption. We recently investigated cortisol and aldosterone 
concentrations pre and post ACTH (i.e. during an ACTH stimulation test) in 19 healthy dogs, 22 
dogs with diseases mimicking AD and in 70 dogs with AD. Healthy dogs and dogs with mimicking 
diseases showed a significant increase in cortisol and aldosterone concentration post ACTH, 
whereas neither cortisol nor aldosterone increased in the dogs with AD. Interestingly, 67 of the 70 
dogs with AD had low-undetectable aldosterone concentrations independent of the degree of 
electrolyte abnormalities, e.g. dogs with mild and dogs with severe abnormalities had similar low 
aldosterone concentrations. In 4 dogs with AD, the typical electrolyte abnormalities were lacking, 
e.g. they suffered atypical AD. The striking finding was that in all 4 dogs post-ACTH aldosterone 
concentrations were below the detection limit, meaning that they were able to maintain their 
electrolytes in the normal range without aldosterone. Our results demonstrate that normal 
electrolytes do not necessarily reflect a normally functioning zona glomerulosa. It is, therefore, 
possible that in dogs with atypical AD not only the zona fasciculata/reticularis but also the zona 
glomerulosa is damaged and other mechanisms (most likely intrarenal) help to maintain a normal 
electrolyte balance. 
However, there may be exceptions as histologic evidence of partially spared zona glomerulosa has 
been described in a small number of dogs. Dogs with typical AD should be treated with gluco- and 
mineralocorticoids. In dogs with atypical AD treatment may initially be limited to the 
administration of glucocorticoids. However, close monitoring is of great importance as electrolyte 
abnormalities (and the need for additional mineralocorticoid replacement) may occur at any time 
during the course of disease.  
With regard to work-up of cases, some important points should be considered: 
 
1. Acute renal failure and AD may look alike as the latter often times is associated with 
azotemia and urine specific gravity < 1.020. Whenever azotemia is found in an acutely ill 
dog, the possibility of AD should be considered.  
2. Most dogs with AD reveal typical electrolyte abnormalities. Hyponatremia and/or 
hyperkalemia should, however, not be equalized with the diagnosis of AD, as various other 
diseases can be associated with similar findings. Confirmation of AD requires the 
documentation of a low cortisol concentration after ACTH administration. A post-ACTH 
cortisol < 55 nmol/l is an inadequate response and consistent with AD. 
3. Some dogs with AD have normal sodium and normal potassium concentrations (atypical 
AD). A high index of suspicion is needed as the clinical presentation is unspecific. We 
routinely measure the baseline cortisol concentration in any dog with an unclear 
presentation. A baseline cortisol concentration > 55 nmol/l excludes the presence of AD, if 
cortisol is < 55 nmol/l and ACTH stimulation test is performed.  
4. To differentiate between atypical AD and secondary hypoadrenocorticism, endogenous 
ACTH should be measured (high in case of (atypical) AD, low in case of secondary 
hypoadrenocorticism).  
5. Diagnosis of hypoadrenocorticism is notoriously difficult in dogs which have received 
glucocorticoids as cortisol levels may be similarly low. Abnormal electrolytes would 
support the diagnosis of AD. If electrolytes abnormalities are missing, measurement of 
endogenous ACTH may be helpful. A very high ACTH concentration would support the 
diagnosis of AD, mild to moderate increases, however, may also be seen in dogs which have 
previously been treated with glucocorticoids.   
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